PTGS2 and MMP9 had the highest amplification rates, with DCRGs amplified in bladder cancer, esophagogastric cancer, ovarian cancer, head and neck cancer, and breast cancer (Figure 5D). The gene discussed is MMP9; the disease is breast carcinoma.